14 Jun 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide presentation at Sedermeradagen in Stockholm and Investordagen in Aalborg


November 25, 2019

FluoGuide A/S’s ("FluoGuide") presented the company and its preparation of FG001 for the proof-of-concept study progresses accordingly to plan.

At Sedermeradagen in Stockholm, Morten Albrechtsen, CEO and Andreas Kjaer, CSO presented in front of approx. 300 investors. The presentation was done in English and a filmed version is available via this link ( It is also available on FluoGuide’s home page together with the presentation.

FluoGuide also presented at Investordagen in Aalborg on the 19th of November 2019. A link to the filmed version will be published on FluoGuide’s home page when available.